Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Given the limited efficacy of current interventions and the complexity of chronic pain, identifying perpetuating factors is crucial for uncovering new mechanistic pathways and treatment targets. The oral and gut microbiome has emerged as a potential modulator of pain through immune, metabolic, and neural mechanisms. Contemporary evidence indicates that chronic pain populations exhibit altered oral and gut microbiota, characterized by reduced short-chain fatty acid (SCFA)-producing taxa and an overrepresentation of pro-inflammatory species. These compositional changes affect metabolites such as SCFAs, bile acids, and microbial cell wall components, which interact with host receptors to promote peripheral and central sensitization. Microbiota-derived metabolites modulate peripheral sensitization by altering nociceptive neuron excitability and stimulating immune cells to release pro-inflammatory cytokines that increase blood–brain barrier permeability, activate microglia, and amplify neuroinflammation. Activated microglia further disrupt the balance between excitatory and inhibitory neurotransmission by enhancing glutamatergic activity and weakening GABAergic signaling, thereby contributing to the induction and maintenance of central sensitization. While observational studies establish associations between dysbiosis and chronic pain, animal models and early human fecal microbiota transplantation studies suggest a potential causal role of dysbiosis in pain, although human evidence remains preliminary and influenced by diet, lifestyle, and comorbidities. Overall, microbiota appears to regulate pain via peripheral and central mechanisms, and targeting it through specific interventions, such as dietary modulation to enhance SCFA production, alongside broader lifestyle measures like sleep, physical activity, stress management, and oral hygiene, may represent a new therapeutic strategy for the management of chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interstitial cystitis/bladder pain syndrome (IC/BPS) and fibromyalgia (FM) are chronic pain conditions that are frequently discussed within overlapping conceptual frameworks, including central sensitization and multisystem symptom amplification1,2.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966 · cited 4×
“Accordingly, Porphyromonas gingivalis and its gingipain proteases were detected in brain tissue and cerebrospinal fluid of Alzheimer’s disease patients, where their presence correlated with neuroinflammatory signaling [89].”
InfluentialNeuroinflammation and Central Sensitization in Chronic and Widespread Pain
Ji, R.-R., Nackley, A., Huh, Y., Terrando, N., & Maixner, W. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002130 · Cited by 1,630 · cited 2×
“This downregulates neuronal potassium-chloride cotransporter 2 (KCC2), causing chloride accumulation and GABAergic disinhibition in neuropathy models [14,105].”
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513
Treatment of periodontitis and endothelial function
Tonetti, M. S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A. D., Vallance, P., & Deanfield, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063186 · Cited by 1,326
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189 · cited 1×
“Microbial metabolites and commensal signals influence brain and pain pathways through vagal afferents projecting from the gut to brainstem nuclei, where serotonergic, opioid, and cholinergic anti-inflammatory circuits modulate nociception, stress responses, and systemic inflammation [17,27,121–125].”
Spermidine in health and disease
Madeo, F., Eisenberg, T., Pietrocola, F., & Kroemer, G. (2018) · Science · doi:10.1126/science.aan2788 · Cited by 1,154
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., & Weiser, J. N. (2010) · Nature Medicine · doi:10.1038/nm.2087 · Cited by 1,154 · cited 1×
“…by host pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs, including NOD1 and NOD2), potentially promoting low-grade inflammation and systemic immune activation when gut barrier function is impaired [75–77].”
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · cited 2×
“While acute cortisol effects imply strong anti-inflammatory properties, chronic elevation of cortisol alters microbiota [27], increases gut permeability [143], and promotes neuroinflammation [144].”
Control of brain development, function, and behavior by the microbiome
Sampson, T. R., & Mazmanian, S. K. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.011 · Cited by 1,093 · cited 1×
“…in gut microbiome composition, termed dysbiosis [16], can increase intestinal permeability [19], promote systemic inflammation [27], and have been linked to a wide range of diseases, including inflammatory [28], metabolic [29], neurological [30–32], and chronic pain conditions [13,14,27,32].”
Ectopic colonization of oral bacteria in the intestine drives T H 1 cell induction and inflammation
Atarashi, K., Suda, W., Luo, C., Kawaguchi, T., Motoo, I., Narushima, S., Kiguchi, Y., Yasuma, K., Watanabe, E., Tanoue, T., et al. (2017) · Science · doi:10.1126/science.aan4526 · Cited by 957 · cited 1×
“Oral microbes can translocate to the distal gut via the enteric pathway through daily saliva swallowing, with humans producing approximately 1 to 1.5 L of saliva containing around 1.5 × 10 12 bacteria per day [101].”
InfluentialNogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917
Chou, R., Deyo, R., Friedly, J., Skelly, A., Hashimoto, R., Weimer, M., Fu, R., Dana, T., Kraegel, P., Griffin, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2459 · Cited by 855
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835 · cited 2×
“Reduction → ↓ SCFAs, ↑ cytokines, ↑ low-grade inflammation [172,223] Odoribacter splanchnicus ↓ in bladder pain, migraine, ME/CFS [13], IBS [224] Migraine, ME/CFS, Bladder pain: Meta-analysis of Human observational studies [13].”
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813 · cited 2×
“The hypothalamic–pituitary–adrenal (HPA) axis regulates stress responses and modulates the gut–brain axis through corticotropin-releasing hormone (CRH)- and adreno-corticotropic hormone (ACTH)-driven cortisol release [132–134].”
The role of microbiome in central nervous system disorders
Wang, Y., & Kasper, L. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.015 · Cited by 803
Duncan, S. H., Barcenilla, A., Stewart, C. S., Pryde, S. E., & Flint, H. J. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.10.5186-5190.2002 · Cited by 743 · cited 2×
“SCFA producers (Acetate and Butyrate) [212,217–221] regulate HDAC/GPR [204,213], support gut homeostasis [217] and may reduce depression and neuroinflammation [222].”
Essex, M. J., Klein, M. H., Cho, E., & Kalin, N. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01553-6 · Cited by 698
Relevance of protein fermentation to gut health
Windey, K., De Preter, V., & Verbeke, K. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100542 · Cited by 692 · cited 1×
“…in the colon, producing amino acid-derived metabolites such as branched-chain fatty acids (isobutyrate, 2-methylbutyrate, isovalerate), phenylacetic acid, and other compounds, including phenols, indoles, p-cresol, amines, and ammonia, contributing minimally to the total SCFA pool [56,61,64,65].”
The oral microbiome: diversity, biogeography and human health
Baker, J. L., Mark Welch, J. L., Kauffman, K. M., McLean, J. S., & He, X. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00963-6 · Cited by 661
Exercise Modifies the Gut Microbiota with Positive Health Effects
Monda, V., Villano, I., Messina, A., Valenzano, A., Esposito, T., Moscatelli, F., Viggiano, A., Cibelli, G., Chieffi, S., Monda, M., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3831972 · Cited by 654
Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men
Buxton, O. M., Pavlova, M., Reid, E. W., Wang, W., Simonson, D. C., & Adler, G. K. (2010) · Diabetes · doi:10.2337/db09-0699 · Cited by 604 · cited 1×
“Sleep restriction to 4–5 h per night for one week impairs glucose tolerance and reduces tissue insulin sensitivity [282].”
A metabolic pathway for bile acid dehydroxylation by the gut microbiome
Funabashi, M., Grove, T. L., Wang, M., Varma, Y., McFadden, M. E., Brown, L. C., Guo, C., Higginbottom, S., Almo, S. C., & Fischbach, M. A. (2020) · Nature · doi:10.1038/s41586-020-2396-4 · Cited by 590 · cited 1×
“…escaping enterohepatic recirculation are deconjugated by bile salt hydrolases and converted via 7 α -dehydroxylation by Clostridium (clusters XIVa and XI), Eu-bacterium , and Bacteroides into secondary bile acids such as deoxycholic and lithocholic acids, encoded in the bai operon [61,67,69–71].”
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576
Oral Microbiome Metabolism: From “Who Are They?” to “What Are They Doing?”
Takahashi, N. (2015) · Journal of Dental Research · doi:10.1177/0022034515606045 · Cited by 488 · cited 1×
“Carbohydrates are fermented into monosaccharides and further converted to pyruvate via glycolysis or the pentose phosphate pathway [48].”
Gut microbiota and the neuroendocrine system
Farzi, A., Fröhlich, E. E., & Holzer, P. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0600-5 · Cited by 478
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2013) · Gut Microbes · doi:10.4161/gmic.25487 · Cited by 448 · cited 1×
“Converts glutamate to GABA [32]; acetate production [229]; regulates cytokines [229–231], reduces pain sensitivity [232–234] Reduction → ↓ GABA, weaker anti-inflammatory control, ↑ excitability Eggerthella lenta ↑ in migraine [13], ME/CFS [235] Migraine: Meta-analysis of Human observational studies…”
Russell, W. R., Duncan, S. H., Scobbie, L., Duncan, G., Cantlay, L., Calder, A. G., Anderson, S. E., & Flint, H. J. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200594 · Cited by 417
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415
Gut Microbiota: An Integral Moderator in Health and Disease
Feng, Q., Chen, W.-D., & Wang, Y.-D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00151 · Cited by 407 · cited 1×
“The gut microbiome interacts with immune cells to modulate cytokine levels and prostaglandin signaling to influence brain function [17,115].”
Bonaz, B., Sinniger, V., & Pellissier, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01452 · Cited by 405
Ilievski, V., Zuchowska, P. K., Green, S. J., Toth, P. T., Ragozzino, M. E., Le, K., Aljewari, H. W., O’Brien-Simpson, N. M., Reynolds, E. C., & Watanabe, K. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204941 · Cited by 372
Li, N., Wang, Q., Wang, Y., Sun, A., Lin, Y., Jin, Y., & Li, X. (2019) · Stress · doi:10.1080/10253890.2019.1617267 · Cited by 327 · cited 1×
“Similarly, in rodents, FMT from donors exposed to chronic unpredictable mild stress induced anxiety and depression-like behaviors, often comorbid with pain, and was accompanied by hippocampal neuroinflammation and altered neurotransmitter levels [257].”
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability
de Punder, K., & Pruimboom, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00223 · Cited by 321 · cited 2×
“While acute cortisol effects imply strong anti-inflammatory properties, chronic elevation of cortisol alters microbiota [27], increases gut permeability [143], and promotes neuroinflammation [144].”
Heim, C., Ehlert, U., Hanker, J. P., & Hellhammer, D. H. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199805000-00017 · Cited by 309
McVey Neufeld, K. A., Mao, Y. K., Bienenstock, J., Foster, J. A., & Kunze, W. A. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12049 · Cited by 299 · cited 1×
“In the absence of commensal microbiota, enteric sensory neurons display reduced excitability and altered membrane properties, which normalize following microbial colonization, underscoring the essential role of gut microbes in maintaining enteric neuronal and sensory function [130].”
Commensal microbiota is fundamental for the development of inflammatory pain
Amaral, F. A., Sachs, D., Costa, V. V., Fagundes, C. T., Cisalpino, D., Cunha, T. M., Ferreira, S. H., Cunha, F. Q., Silva, T. A., Nicoli, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711891105 · Cited by 289 · cited 1×
“Similarly, dysbiosis is associated with increased production of pro-inflammatory cytokines such as IL-1 β and TNF-α , which can cross the blood–brain barrier and activate microglia, sustaining neuroinflammatory cascades and facilitating central sensitization [117,118].”
A selective gut bacterial bile salt hydrolase alters host metabolism
Yao, L., Seaton, S. C., Ndousse-Fetter, S., Adhikari, A. A., DiBenedetto, N., Mina, A. I., Banks, A. S., Bry, L., & Devlin, A. S. (2018) · eLife · doi:10.7554/elife.37182 · Cited by 274 · cited 1×
“LPS producers [238]; bile acid metabolism [239]; activate TLR4 → NF-κ B [238,240] Overgrowth → ↑ LPS/TLR4 signaling [238,240], systemic inflammation [238,240] Oral Dysbiosis”
Mullish, B. H., McDonald, J. A. K., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F., Kapila, D., Petrof, E. O., Joyce, S. A., Gahan, C. G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317842 · Cited by 268 · cited 2×
“Blautia obeum (formerly known as Ruminococcus obeum ), reduced in migraine and ME/CFS, ferments carbohydrates to produce acetate and propionate [179–183], potentially supporting epithelial and immune function and participating in bile acid metabolism [184] (Table 1).”
InfluentialFrom Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00305 · Cited by 249 · cited 1×
“SCFAs inhibit HDACs to acetylate and stabilize MAPK phosphatase-1 (MKP-1), enabling dephosphorylation of ERK/JNK/p38 and reducing downstream inflammatory signals [133,161].”
Kamiya, T., Wang, L., Forsythe, P., Goettsche, G., Mao, Y., Wang, Y., Tougas, G., & Bienenstock, J. (2006) · Gut · doi:10.1136/gut.2005.070987 · Cited by 242
Perez-Burgos, A., Wang, B., Mao, Y.-K., Mistry, B., Neufeld, K.-A. M., Bienenstock, J., & Kunze, W. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00128.2012 · Cited by 235
Benus, R. F. J., van der Werf, T. S., Welling, G. W., Judd, P. A., Taylor, M. A., Harmsen, H. J. M., & Whelan, K. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001030 · Cited by 210 · cited 1×
“…[203,204] + GPR41/43 activation → suppresses NF-κ B/MAPK [203,205], ↑ IL-10 [206–208], maintains gut barrier [203,209] Reduction → ↓ butyrate [210,211], weaker HDAC/GPR signaling, ↑ NF-κ B activity, ↑ cytokines, sensitization Roseburia spp. ↓ in migraine, ME/CFS [13], and ↑ in FM [13] Migraine,…”
Varghese, S., Rao, S., Khattak, A., Zamir, F., & Chaari, A. (2024) · Nutrients · doi:10.3390/nu16213663 · Cited by 152 · cited 1×
“Regular physical activity has been shown to increase gut microbial diversity, enrich taxa involved in SCFAs metabolism, and reduce both peripheral and central sensitization [278,279].”
Santonocito, S., Giudice, A., Polizzi, A., Troiano, G., Merlo, E. M., Sclafani, R., Grosso, G., & Isola, G. (2022) · Nutrients · doi:10.3390/nu14122426 · Cited by 144
Lifestyle and Chronic Pain across the Lifespan: An Inconvenient Truth?
Nijs, J., D'Hondt, E., Clarys, P., Deliens, T., Polli, A., Malfliet, A., Coppieters, I., Willaert, W., Tumkaya Yilmaz, S., Elma, Ö., et al. (2020) · PM&R · doi:10.1002/pmrj.12244 · Cited by 121 · cited 1×
“Contemporary evidence shows that lifestyle factors such as physical inactivity, stress, poor sleep, unhealthy diet, and smoking are not only associated with chronic pain across age groups [264–267] but also shape gut microbiome composition [263].”
Self-citationAndrés-Rodríguez, L., Borràs, X., Feliu-Soler, A., Pérez-Aranda, A., Angarita-Osorio, N., Moreno-Peral, P., Montero-Marin, J., García-Campayo, J., Carvalho, A. F., Maes, M., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.020 · Cited by 95
Feng, Y.-K., Wu, Q.-L., Peng, Y.-W., Liang, F.-Y., You, H.-J., Feng, Y.-W., Li, G., Li, X.-J., Liu, S.-H., Li, Y.-C., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02027-5 · Cited by 87
Rosier, B. T., Johnston, W., Carda-Diéguez, M., Simpson, A., Cabello-Yeves, E., Piela, K., Reilly, R., Artacho, A., Easton, C., Burleigh, M., et al. (2024) · International Journal of Oral Science · doi:10.1038/s41368-023-00266-9 · Cited by 85
Eberhard, J., Grote, K., Luchtefeld, M., Heuer, W., Schuett, H., Divchev, D., Scherer, R., Schmitz-Streit, R., Langfeldt, D., Stumpp, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055265 · Cited by 75
Bostanghadiri, N., Kouhzad, M., Taki, E., Elahi, Z., Khoshbayan, A., Navidifar, T., & Darban-Sarokhalil, D. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1431785 · Cited by 61 · cited 1×
“These communities generate diverse metabolites that shape oral health largely through immune regulation [33,47].”
Fang, H., Hou, Q., Zhang, W., Su, Z., Zhang, J., Li, J., Lin, J., Wang, Z., Yu, X., Yang, Y., et al. (2024) · The Journal of Pain · doi:10.1016/j.jpain.2024.104535 · Cited by 33 · cited 1×
“A pilot study in treatment-resistant fibromyalgia re-ported symptom relief, including pain reduction, following FMT from healthy donors [261].”
Research works printed but not linked: 235
- Ferreira, 2023, Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021, Lancet Rheumatol., 5, e316, 10.1016/S2665-9913(23)00098-X · DOI · Paper page
- Abd-Elsayed, A. (2020). Economic Burden of Pain. Guide to the Inpatient Pain Consult, Springer International Publishing. · doi:10.1007/978-3-030-40449-9
- Nijs, J., Malfliet, A., Roose, E., Lahousse, A., Van Bogaert, W., Johansson, E., Runge, N., Goossens, Z., Labie, C., and Bilterys, T. (2024). Personalized multimodal lifestyle intervention as the best-evidenced treatment for chronic pain: State-of-the-art clinical perspective. J. Clin. Med., 13. · DOI
- Eccleston, 2019, Pharmacological interventions for chronic pain in children: An overview of systematic reviews, Pain, 160, 1698, 10.1097/j.pain.0000000000001609 · DOI
- McDonagh, M.S., Selph, S.S., Buckley, D.I., Holmes, R.S., Mauer, K., Ramirez, S., Hsu, F.C., Dana, T., Fu, R., and Chou, R. (2020). Nonopioid Pharmacologic Treatments for Chronic Pain, American Academy of Family Physicians. · DOI
- Chou, 2017, Systemic pharmacologic therapies for low back pain: A systematic review for an American College of Physicians clinical practice guideline, Ann. Intern. Med., 166, 480, 10.7326/M16-2458 · DOI · Paper page
- Billens, 2022, Systemic Cytokine Level Differences in Patients with Chronic Musculoskeletal Spinal Pain Compared to Healthy Controls and Its Association with Pain Severity: A Systematic Review, Pain Med., 23, 1947, 10.1093/pm/pnac091 · DOI
- Nijs, 2021, Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine, Lancet Rheumatol., 3, e383, 10.1016/S2665-9913(21)00032-1 · DOI · Paper page
- Guo, 2019, Pain regulation by gut microbiota: Molecular mechanisms and therapeutic potential, Br. J. Anaesth., 123, 637, 10.1016/j.bja.2019.07.026 · DOI · Paper page
- Goudman, L., Demuyser, T., Pilitsis, J.G., Billot, M., Roulaud, M., Rigoard, P., and Moens, M. (2024). Gut dysbiosis in patients with chronic pain: A systematic review and meta-analysis. Front. Immunol., 15. · DOI
- Zhao, M., Zhang, L., and Liu, Z. (2025). Gut microbiota-mediated pain sensitization: Mechanisms and therapeutic implications. Front. Pain Res., 6. · DOI
- Adil, N.A., Omo-Erigbe, C., Yadav, H., and Jain, S. (2025). The oral–gut microbiome–brain axis in cognition. Microorganisms, 13. · DOI
- 2024, Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia: A systematic review, Int. J. Rheum. Dis., 27, e15021, 10.1111/1756-185X.15021 · DOI
- Sejbuk, M., Siebieszuk, A., and Witkowska, A.M. (2024). The role of gut microbiome in sleep quality and health: Dietary strategies for microbiota support. Nutrients, 16. · DOI
- Olsen, 2019, Can oral bacteria affect the microbiome of the gut?, J. Oral Microbiol., 11, 1586422, 10.1080/20002297.2019.1586422 · DOI · Paper page
- Liu, S., Li, G., Zhu, Y., Xu, C., Yang, Q., Xiong, A., Weng, J., Yu, F., and Zeng, H. (2022). Analysis of gut microbiome composition, function, and phenotype in patients with osteoarthritis. Front. Microbiol., 13. · DOI
- Erdrich, S., Gelissen, I.C., Vuyisich, M., Toma, R., and Harnett, J.E. (2025). An association between poor oral health, oral microbiota, and pain identified in New Zealand women with central sensitisation disorders: A prospective clinical study. Front. Pain Res., 6. · DOI
- Costa, C.F., Correia-de-Sá, T., Araujo, R., Barbosa, F., Burnet, P.W., Ferreira-Gomes, J., and Sampaio-Maia, B. (2024). The oral-gut microbiota relationship in healthy humans: Identifying shared bacteria between environments and age groups. Front. Microbiol., 15. · DOI
- Blekhman, 2015, Host genetic variation impacts microbiome composition across human body sites, Genome Biol., 16, 191, 10.1186/s13059-015-0759-1 · DOI · Paper page
- Markle, 2013, Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity, Science, 339, 1084, 10.1126/science.1233521 · DOI · Paper page
- Rajasekaran, J.J., Krishnamurthy, H.K., Bosco, J., Jayaraman, V., Krishna, K., Wang, T., and Bei, K. (2024). Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms, 12. · doi:10.20944/preprints202406.1923.v1
- Govender, 2025, Population-specific differences in the human microbiome: Factors defining the diversity, Gene, 933, 148923, 10.1016/j.gene.2024.148923 · DOI
- Ho, T., Elma, Ö., Kocanda, L., Brain, K., Lam, T., Kanhere, T., and Dong, H.-J. (2025). The brain-gut axis and chronic pain: Mechanisms and therapeutic opportunities. Front. Neurosci., 19. · DOI
- Kennedy, 2014, Irritable bowel syndrome: A microbiome-gut-brain axis disorder?, World J. Gastroenterol. WJG, 20, 14105, 10.3748/wjg.v20.i39.14105 · DOI · Paper page
- Karlsson, 2013, Assessing the human gut microbiota in metabolic diseases, Diabetes, 62, 3341, 10.2337/db13-0844 · DOI · Paper page
- Abecia, 2019, Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia, eBioMedicine, 46, 499, 10.1016/j.ebiom.2019.07.031 · DOI · Paper page
- Manske, 2024, The Microbiome’s Role in Chronic Pain and Inflammation, Integr. Med., 23, 10
- Erdrich, 2025, Characterisation of the Oral Microbiome in Women With Fibromyalgia: An Observational Case–Control Study, Eur. J. Pain, 29, e70051, 10.1002/ejp.70051 · DOI
- Kroese, 2021, Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals, Arthritis Rheumatol., 73, 1986, 10.1002/art.41780 · DOI
- Ma, 2022, Fibromyalgia and periodontitis: Bidirectional associations in population-based 15-year retrospective cohorts, J. Periodontol., 93, 877, 10.1002/JPER.21-0256 · DOI
- Chen, X., Xue, D., Zhao, Y., Cui, P., Wang, P., Wang, Y., and Lu, S.B. (2023). Association between periodontitis and disc structural failure in older adults with lumbar degenerative disorders: A prospective cohort study. BMC Surg., 23. · DOI
- Dietrich, 2008, Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population, J. Rheumatol., 35, 70
- Liu, X.-f., Shao, J.-h., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-j., Liu, Z.-z., He, D.-d., Li, C., and Zhang, X. (2023). Regulation of short-chain fatty acids in the immune system. Front. Immunol., 14. · DOI · Paper page
- Xu, 2025, The oral-gut microbiota axis: A link in cardiometabolic diseases, npj Biofilms Microbiomes, 11, 11, 10.1038/s41522-025-00646-5 · DOI
- Kitamoto, 2020, The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis, Cell, 182, 447, 10.1016/j.cell.2020.05.048 · DOI · Paper page
- Guo, 2024, Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa, Gut Microbes, 16, 2333463, 10.1080/19490976.2024.2333463 · DOI
- Li, 2024, Oral inoculation of Fusobacterium nucleatum exacerbates ulcerative colitis via the secretion of virulence adhesin FadA, Virulence, 15, 2399217, 10.1080/21505594.2024.2399217 · DOI
- Tsuzuno, 2021, Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice, J. Periodontal Res., 56, 275, 10.1111/jre.12816 · DOI
- Sohn, 2022, Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4(+) T cells, Mol. Oral Microbiol., 37, 42, 10.1111/omi.12359 · DOI
- Jie, Z., Ziyi, J., Yu, F., Gao, L., Wang, X., and Wang, Q. (2025). Integrated oral-gut microbiota therapy: A novel perspective on preventing bacterial translocation for systemic disease management. Front. Cell. Infect. Microbiol., 15. · DOI
- Leonov, G.E., Varaeva, Y.R., Livantsova, E.N., and Starodubova, A.V. (2023). The Complicated Relationship of Short-Chain Fatty Acids and Oral Microbiome: A Narrative Review. Biomedicines, 11. · DOI
- Ndeh, 2018, Biochemistry of complex glycan depolymerisation by the human gut microbiota, FEMS Microbiol. Rev., 42, 146, 10.1093/femsre/fuy002 · DOI · Paper page
- Santacroce, 2023, Oral microbiota in human health and disease: A perspective, Exp. Biol. Med., 248, 1288, 10.1177/15353702231187645 · DOI
- Magrin, G.L., Strauss, F.J., Benfatti, C.A.M., Maia, L.C., and Gruber, R. (2020). Effects of Short-Chain Fatty Acids on Human Oral Epithelial Cells and the Potential Impact on Periodontal Disease: A Systematic Review of In Vitro Studies. Int. J. Mol. Sci., 21. · DOI
- Zhang, 2023, The Commensal Anaerobe Veillonella dispar Reprograms Its Lactate Metabolism and Short-Chain Fatty Acid Production during the Stationary Phase, Microbiol. Spectr., 11, e0355822, 10.1128/spectrum.03558-22 · DOI
- Louis, 2017, Formation of propionate and butyrate by the human colonic microbiota, Environ. Microbiol., 19, 29, 10.1111/1462-2920.13589 · DOI · Paper page
- Koh, 2016, From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041 · DOI · Paper page
- Wong, 2006, Colonic health: Fermentation and short chain fatty acids, J. Clin. Gastroenterol., 40, 235, 10.1097/00004836-200603000-00015 · DOI · Paper page
- Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., and Ruffolo, C. (2024). Short-chain fatty acids and human health: From metabolic pathways to current therapeutic implications. Life, 14. · DOI
- Hodgkinson, 2023, Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease, Clin. Nutr., 42, 61, 10.1016/j.clnu.2022.10.024 · DOI · Paper page
- Louis, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat. Rev. Microbiol., 12, 661, 10.1038/nrmicro3344 · DOI · Paper page
- Groen, 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res., 54, 2325, 10.1194/jlr.R036012 · DOI · Paper page
- Agus, 2018, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host Microbe, 23, 716, 10.1016/j.chom.2018.05.003 · DOI · Paper page
- Rebeaud, J., Peter, B., and Pot, C. (2022). How microbiota-derived metabolites link the gut to the brain during neuroinflammation. Int. J. Mol. Sci., 23. · DOI
- Ridlon, 2006, Bile salt biotransformations by human intestinal bacteria, J. Lipid Res., 47, 241, 10.1194/jlr.R500013-JLR200 · DOI · Paper page
- Guzior, 2021, Microbial transformations of human bile acids, Microbiome, 9, 140, 10.1186/s40168-021-01101-1 · DOI · Paper page
- Raetz, 2002, Lipopolysaccharide endotoxins, Annu. Rev. Biochem., 71, 635, 10.1146/annurev.biochem.71.110601.135414 · DOI · Paper page
- Typas, 2011, From the regulation of peptidoglycan synthesis to bacterial growth and morphology, Nat. Rev. Microbiol., 10, 123, 10.1038/nrmicro2677 · DOI · Paper page
- Rahman, 2023, The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects, Curr. Rheumatol. Rep., 25, 307, 10.1007/s11926-023-01108-7 · DOI
- Vargas, 2025, Gut microbiota-derived metabolites and chronic inflammatory diseases, Explor. Med., 6, 1001275, 10.37349/emed.2025.1001275 · DOI
- Matsuda, 2024, Effect of periodontal treatment on reducing chronic inflammation in systemically healthy patients with periodontal disease, Am. J. Med., 137, 273, 10.1016/j.amjmed.2023.11.001 · DOI
- Brito, 2013, Experimental periodontitis promotes transient vascular inflammation and endothelial dysfunction, Arch. Oral Biol., 58, 1187, 10.1016/j.archoralbio.2013.03.009 · DOI
- Yue, Z., Fan, Y., Shan, G., and Chen, X. (2025). Oral microbiome contributions to metabolic syndrome pathogenesis. Front. Microbiol., 16. · DOI
- Carrouel, F., Viennot, S., Santamaria, J., Veber, P., and Bourgeois, D. (2016). Quantitative molecular detection of 19 major pathogens in the interdental biofilm of periodontally healthy young adults. Front. Microbiol., 7. · DOI
- Lamont, R.J., and Kuboniwa, M. (2024). The polymicrobial pathogenicity of Porphyromonas gingivalis. Front. Oral Health, 5. · DOI
- Groeger, S., Jarzina, F., Domann, E., and Meyle, J. (2017). Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunol., 18. · DOI
- Park, S.Y., Hwang, B.O., Lim, M., Ok, S.H., Lee, S.K., Chun, K.S., Park, K.K., Hu, Y., Chung, W.Y., and Song, N.Y. (2021). Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers, 13. · DOI · Paper page
- Lu, J., Wang, Y., Wu, J., Duan, Y., Zhang, H., and Du, H. (2025). Linking microbial communities to rheumatoid arthritis: Focus on gut, oral microbiome and their extracellular vesicles. Front. Immunol., 16. · DOI
- Wu, H., Qiu, W., Zhu, X., Li, X., Xie, Z., Carreras, I., Dedeoglu, A., Van Dyke, T., Han, Y.W., and Karimbux, N. (2022). The periodontal pathogen fusobacterium nucleatum exacerbates Alzheimer’s pathogenesis via specific pathways. Front. Aging Neurosci., 14. · DOI
- Oue, 2024, Oral administration of Porphyromonas gingivalis to mice with diet-induced obesity impairs cognitive function associated with microglial activation in the brain, J. Oral Microbiol., 16, 2419155, 10.1080/20002297.2024.2419155 · DOI
- Olsen, 2016, Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases, J. Oral Microbiol., 8, 30385, 10.3402/jom.v8.30385 · DOI
- Hu, 2021, Activated STAT3 signaling pathway by ligature-induced periodontitis could contribute to neuroinflammation and cognitive impairment in rats, J. Neuroinflamm, 18, 80, 10.1186/s12974-021-02071-9 · DOI
- Nagashima, 2017, CXCR4 signaling in macrophages contributes to periodontal mechanical hypersensitivity in Porphyromonas gingivalis-induced periodontitis in mice, Mol. Pain, 13, 1744806916689269, 10.1177/1744806916689269 · doi:10.1177/1744806916689269
- Kaewpitak, 2020, Porphyromonas gingivalis lipopolysaccharide rapidly activates trigeminal sensory neurons and may contribute to pulpal pain, Int. Endod. J., 53, 846, 10.1111/iej.13282 · DOI
- Shimizu, K., Matsumoto, K., Noma, N., Matsuura, S., Ohara, K., Komiya, H., Watase, T., Ogiso, B., Tsuboi, Y., and Shinoda, M. (2014). Involvement of trigeminal transition zone and laminated subnucleus caudalis in masseter muscle hypersensitivity associated with tooth inflammation. PLoS ONE, 9. · DOI
- Worsley, 2014, Chronic tooth pulp inflammation induces persistent expression of phosphorylated ERK (pERK) and phosphorylated p38 (pp38) in trigeminal subnucleus caudalis, Neuroscience, 269, 318, 10.1016/j.neuroscience.2014.03.056 · doi:10.1016/j.neuroscience.2014.03.056
- Yamazaki, 2024, Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases, Mucosal Immunol., 17, 147, 10.1016/j.mucimm.2023.11.006 · DOI
- Yamazaki, 2023, Oral-gut axis as a novel biological mechanism linking periodontal disease and systemic diseases: A review, Jpn. Dent. Sci. Rev., 59, 273, 10.1016/j.jdsr.2023.08.003 · DOI
- Peng, 2022, Oral microbiota in human systematic diseases, Int. J. Oral Sci., 14, 14, 10.1038/s41368-022-00163-7 · DOI · Paper page
- Nakajima, M., Arimatsu, K., Kato, T., Matsuda, Y., Minagawa, T., Takahashi, N., Ohno, H., and Yamazaki, K. (2015). Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE, 10. · DOI · Paper page
- Bao, 2022, Periodontitis may induce gut microbiota dysbiosis via salivary microbiota, Int. J. Oral Sci., 14, 32, 10.1038/s41368-022-00183-3 · DOI · Paper page
- Gu, X., Song, L.J., Li, L.X., Liu, T., Zhang, M.M., Li, Z., Wang, P., Li, M., and Zuo, X.L. (2020). Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner. Front. Microbiol., 11. · DOI
- Verri, 2017, Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation, Trends Immunol., 38, 5, 10.1016/j.it.2016.10.001 · DOI · Paper page
- Li, Y., Zhu, M., Liu, Y., Luo, B., Cui, J., Huang, L., Chen, K., and Liu, Y. (2022). The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights. Front. Immunol., 13. · DOI
- Fleetwood, A.J., Lee, M.K., Singleton, W., Achuthan, A., Lee, M.-C., O’Brien-Simpson, N.M., Cook, A.D., Murphy, A.J., Dashper, S.G., and Reynolds, E.C. (2017). Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Front. Cell. Infect. Microbiol., 7. · DOI · Paper page
- Haraga, 2022, Effect of the Progression of Fusobacterium nucleatum–induced Apical Periodontitis on the Gut Microbiota, J. Endod., 48, 1038, 10.1016/j.joen.2022.04.014 · DOI
- Tortora, S.C., Agurto, M.G., and Martello, L.A. (2023). The oral-gut-circulatory axis: From homeostasis to colon cancer. Front. Cell. Infect. Microbiol., 13. · DOI
- Pihlstrom, 2005, Periodontal diseases, Lancet, 366, 1809, 10.1016/S0140-6736(05)67728-8 · DOI · Paper page
- Weinstock, 2012, Genomic approaches to studying the human microbiota, Nature, 489, 250, 10.1038/nature11553 · DOI · Paper page
- Luczynski, 2017, Microbiota regulates visceral pain in the mouse, eLife, 6, e25887, 10.7554/eLife.25887 · DOI · Paper page
- Vieira, 2015, A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout, Arthritis Rheumatol., 67, 1646, 10.1002/art.39107 · DOI · Paper page
- Lee, 2023, Nerve injury-induced gut dysbiosis contributes to spinal cord TNF-α expression and nociceptive sensitization, Brain Behav. Immun., 110, 155, 10.1016/j.bbi.2023.03.005 · DOI
- Cai, 2025, The gut microbiota promotes pain in fibromyalgia, Neuron, 113, 2161, 10.1016/j.neuron.2025.03.032 · DOI · Paper page
- Powley, 2008, Ultrastructural evidence for communication between intramuscular vagal mechanoreceptors and interstitial cells of Cajal in the rat fundus, Neurogastroenterol. Motil., 20, 69, 10.1111/j.1365-2982.2007.00990.x · DOI · Paper page
- Morris, 2020, The role of the locus coeruleus in the generation of pathological anxiety, Brain Neurosci. Adv., 4, 2398212820930321, 10.1177/2398212820930321 · DOI · Paper page
- Ma, 2009, Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli, Am. J. Physiol.-Gastrointest. Liver Physiol., 296, G868, 10.1152/ajpgi.90511.2008 · DOI · Paper page
- Jameson, 2025, Select microbial metabolites in the small intestinal lumen regulates vagal activity via receptor-mediated signaling, iScience, 28, 111699, 10.1016/j.isci.2024.111699 · DOI
- Siopi, 2023, Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice, Mol. Psychiatry, 28, 3002, 10.1038/s41380-023-02071-6 · DOI · Paper page
- Woda, 2016, Dysfunctional stress responses in chronic pain, Psychoneuroendocrinology, 71, 127, 10.1016/j.psyneuen.2016.05.017 · DOI
- Tosato, 2015, Correlation of stress and muscle activity of patients with different degrees of temporomandibular disorder, J. Phys. Ther. Sci., 27, 1227, 10.1589/jpts.27.1227 · DOI
- Kim, 2012, Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome, Oral Dis., 18, 613, 10.1111/j.1601-0825.2012.01937.x · DOI
- Nijhof, 2014, The role of hypocortisolism in chronic fatigue syndrome, Psychoneuroendocrinology, 42, 199, 10.1016/j.psyneuen.2014.01.017 · DOI
- Chang, 2009, Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome, Neurogastroenterol. Motil., 21, 149, 10.1111/j.1365-2982.2008.01171.x · DOI · Paper page
- Coppens, 2018, Cortisol and Subjective Stress Responses to Acute Psychosocial Stress in Fibromyalgia Patients and Control Participants, Psychosom. Med., 80, 317, 10.1097/PSY.0000000000000551 · DOI · Paper page
- Bowie, 1998, Activity-dependent modulation of glutamate receptors by polyamines, J. Neurosci., 18, 8175, 10.1523/JNEUROSCI.18-20-08175.1998 · DOI · Paper page
- Kim, 2023, Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity, Cell. Mol. Immunol., 20, 341, 10.1038/s41423-023-00987-1 · DOI · Paper page
- Li, 2018, Pro-and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells, Eur. J. Pharmacol., 831, 52, 10.1016/j.ejphar.2018.05.003 · DOI · Paper page
- Takeda, M., Sashide, Y., and Utugi, S. (2025). Neurophysiological Basis of Short-Chain Fatty Acid Action in Pain Modulation: Therapeutic Implications. Int. J. Mol. Sci., 26. · DOI
- Sashide, Y., Utugi, S., and Takeda, M. (2025). A Short-Chain Fatty Acid, Butyrate, Suppresses the Hyperexcitability of Rat Nociceptive Primary Neurons Involved in Inflammatory Hyperalgesia. Molecules, 30. · DOI
- Takeda, 2009, Contribution of the activation of satellite glia in sensory ganglia to pathological pain, Neurosci. Biobehav. Rev., 33, 784, 10.1016/j.neubiorev.2008.12.005 · DOI · Paper page
- Ruhnke, 2024, Expression of free fatty acid receptor 2 in normal and neoplastic tissues, Exp. Mol. Pathol., 137, 104902, 10.1016/j.yexmp.2024.104902 · DOI
- Taing, 2023, Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain, Neural Regen. Res., 18, 763, 10.4103/1673-5374.354514 · DOI
- Vallabhapurapu, 2009, Regulation and function of NF-κB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641 · DOI · Paper page
- Huang, 2020, Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling, Oxid. Med. Cell. Longev., 2020, 4074832, 10.1155/2020/4074832 · DOI · Paper page
- Lee, 2013, β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-κB, Biol. Pharm. Bull., 36, 1754, 10.1248/bpb.b13-00312 · DOI · Paper page
- Chen, 2001, Duration of nuclear NF-κB action regulated by reversible acetylation, Science, 293, 1653, 10.1126/science.1062374 · DOI · Paper page
- Ni, 2010, Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice, Respir. Res., 11, 33, 10.1186/1465-9921-11-33 · DOI · Paper page
- Place, 2005, HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα, Biochem. Pharmacol., 70, 394, 10.1016/j.bcp.2005.04.030 · DOI · Paper page
- Segain, 2000, Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn’s disease, Gut, 47, 397, 10.1136/gut.47.3.397 · DOI · Paper page
- Liu, 2007, MAPK phosphatases—Regulating the immune response, Nat. Rev. Immunol., 7, 202, 10.1038/nri2035 · DOI · Paper page
- Noureldein, 2018, Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction, Microb. Pathog., 118, 98, 10.1016/j.micpath.2018.03.021 · DOI
- Tycko, 2020, High-throughput discovery and characterization of human transcriptional effectors, Cell, 183, 2020, 10.1016/j.cell.2020.11.024 · DOI · Paper page
- Nijs, 2020, Nutritional intervention in chronic pain: An innovative way of targeting central nervous system sensitization?, Expert Opin. Ther. Targets, 24, 793, 10.1080/14728222.2020.1784142 · DOI
- Mortensen, 2020, Exploring the intersection between genetic risk scores and coronary artery calcium–Mutually exclusive or complementary?, J. Cardiovasc. Comput. Tomogr., 14, 206, 10.1016/j.jcct.2019.05.014 · DOI
- Irwin, 2022, Quantifying and categorising national extinction-risk footprints, Sci. Rep., 12, 5861, 10.1038/s41598-022-09827-0 · DOI
- Grabowska, 2024, Effect of proinflammatory cytokines on blood-brain barrier integrity, Eur. Cytokine Netw., 35, 38, 10.1684/ecn.2024.0498 · DOI
- Zhen, 2021, Greater strength of selection and higher proportion of beneficial amino acid changing mutations in humans compared with mice and Drosophila melanogaster, Genome Res., 31, 110, 10.1101/gr.256636.119 · DOI
- Gao, 2010, Chemokines, neuronal–glial interactions, and central processing of neuropathic pain, Pharmacol. Ther., 126, 56, 10.1016/j.pharmthera.2010.01.002 · DOI · Paper page
- Gao, 2010, Targeting astrocyte signaling for chronic pain, Neurotherapeutics, 7, 482, 10.1016/j.nurt.2010.05.016 · DOI · Paper page
- Tieppo, 2024, Analysis of intestinal bacterial microbiota in individuals with and without chronic low back pain, Curr. Issues Mol. Biol., 46, 7339, 10.3390/cimb46070435 · DOI
- Freidin, 2021, An association between chronic widespread pain and the gut microbiome, Rheumatology, 60, 3727, 10.1093/rheumatology/keaa847 · DOI
- Mugo, 2025, Unravelling the gut-brain connection: A systematic review of migraine and the gut microbiome, J. Headache Pain, 26, 125, 10.1186/s10194-025-02039-7 · DOI
- Bonato, 2022, A systematic review of microbiome composition in osteoarthritis subjects, Osteoarthr. Cartil., 30, 786, 10.1016/j.joca.2021.12.006 · DOI
- Zhu, 2018, Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis, Mol. Med. Rep., 17, 7567
- Luo, 2019, Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response, Mol. Med. Rep., 20, 1007
- Hiippala, K., Barreto, G., Burrello, C., Diaz-Basabe, A., Suutarinen, M., Kainulainen, V., Bowers, J.R., Lemmer, D., Engelthaler, D.M., and Eklund, K.K. (2020). Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro. Front. Microbiol., 11. · DOI · Paper page
- Xing, 2021, Microbiota regulate innate immune signaling and protective immunity against cancer, Cell Host Microbe, 29, 959, 10.1016/j.chom.2021.03.016 · DOI · Paper page
- Moore, 1976, Emendation of Bacteroidaceae and Butyrivibrio and descriptions of Desulfomonas gen. nov. and ten new species in the genera Desulfomonas, Butyrivibrio, Eubacterium, Clostridium, and Ruminococcus, Int. J. Syst. Evol. Microbiol., 26, 238
- Nguyen, 2020, Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate, Microbiome, 8, 118, 10.1186/s40168-020-00887-w · DOI · Paper page
- Liu, 2021, Blautia-a new functional genus with potential probiotic properties?, Gut Microbes, 13, 1875796, 10.1080/19490976.2021.1875796 · DOI · Paper page
- Wang, 2023, Ginsenoside Rg3 enriches SCFA-producing commensal bacteria to confer protection against enteric viral infection via the cGAS-STING-type I IFN axis, ISME J., 17, 2426, 10.1038/s41396-023-01541-7 · DOI
- Zheng, 2024, Noninvasive, microbiome-based diagnosis of inflammatory bowel disease, Nat. Med., 30, 3555, 10.1038/s41591-024-03280-4 · DOI
- Liu, 2020, Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation, J. Transl. Med., 18, 382, 10.1186/s12967-020-02539-x · DOI
- Li, 2021, Microbiome-encoded bile acid metabolism modulates colonic transit times, iScience, 24, 102508, 10.1016/j.isci.2021.102508 · DOI
- Li, X., Yao, Z., Qian, J., Li, H., and Li, H. (2024). Lactate Protects Intestinal Epithelial Barrier Function from Dextran Sulfate Sodium-Induced Damage by GPR81 Signaling. Nutrients, 16. · DOI
- Baker, 2024, Protease-induced excitation of dorsal root ganglion neurons in response to acute perturbation of the gut microbiota is associated with visceral and somatic hypersensitivity, Cell. Mol. Gastroenterol. Hepatol., 18, 101334, 10.1016/j.jcmgh.2024.03.006 · DOI
- Balakrishnan, 2023, Eggerthella lenta augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritis, Sci. Adv., 9, eadg1129, 10.1126/sciadv.adg1129 · DOI
- Taneja, 2018, AB0137 Arthritis-associated eggerthella lenta modulate disease via metabolic and microbial alterations, Ann. Rheum. Dis., 77, 1260, 10.1136/annrheumdis-2018-eular.3179 · doi:10.1136/annrheumdis-2018-eular.3179
- Liu, 2024, Tryptophan metabolites and gut microbiota play an important role in pediatric migraine diagnosis, J. Headache Pain, 25, 2, 10.1186/s10194-023-01708-9 · DOI
- Papetti, 2024, Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation, J. Headache Pain, 25, 171, 10.1186/s10194-024-01871-7 · DOI
- Lanza, M., Filippone, A., Casili, G., Giuffrè, L., Scuderi, S.A., Paterniti, I., Campolo, M., Cuzzocrea, S., and Esposito, E. (2022). Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine. Int. J. Mol. Sci., 23. · DOI
- Wang, D., Liu, X., Shi, S., Ren, T., and Wang, W. (2024). Gut microbiota and metabolite variations in a migraine mouse model. Front. Cell. Infect. Microbiol., 13. · DOI
- Saija, C., Bertuccio, M.P., Scoglio, A., Macaione, V., Cacciola, F., Micalizzi, G., Caccamo, D., Muscoli, C., and Currò, M. (2025). Role of Vitamin D Status and Alterations in Gut Microbiota Metabolism in Fibromyalgia-Associated Chronic Inflammatory Pain. Biomedicines, 13. · DOI
- Cheng, 2025, Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome, Sci. Rep., 15, 43681, 10.1038/s41598-025-27564-y · DOI
- Guo, 2023, Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS, Cell Host Microbe, 31, 288, 10.1016/j.chom.2023.01.004 · DOI · Paper page
- Ceccarelli, 2018, Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients, Clin. Exp. Immunol., 194, 244, 10.1111/cei.13184 · DOI
- Li, Y., Guo, R., Oduro, P.K., Sun, T., Chen, H., Yi, Y., Zeng, W., Wang, Q., Leng, L., and Yang, L. (2022). The Relationship Between Porphyromonas Gingivalis and Rheumatoid Arthritis: A Meta-Analysis. Front. Cell. Infect. Microbiol., 12. · doi:10.3389/fcimb.2022.956417
- Fteita, 2022, Prevotella species as oral residents and infectious agents with potential impact on systemic conditions, J. Oral Microbiol., 14, 2079814, 10.1080/20002297.2022.2079814 · DOI · Paper page
- Shibata, 1997, Mycoplasma salivarium induces interleukin-6 and interleukin-8 in human gingival fibroblasts, FEMS Immunol. Med. Microbiol., 19, 275, 10.1111/j.1574-695X.1997.tb01097.x · DOI
- Picchianti-Diamanti, A., Panebianco, C., Salemi, S., Sorgi, M.L., Di Rosa, R., Tropea, A., Sgrulletti, M., Salerno, G., Terracciano, F., and D’Amelio, R. (2018). Analysis of gut microbiota in rheumatoid arthritis patients: Disease-related dysbiosis and modifications induced by etanercept. Int. J. Mol. Sci., 19. · DOI · Paper page
- Zhang, 2021, Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture, Med, 2, 74, 10.1016/j.medj.2020.07.001 · DOI
- Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. Sci. USA, 111, 2247, 10.1073/pnas.1322269111 · DOI · Paper page
- Inan, 2000, The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line, Gastroenterology, 118, 724, 10.1016/S0016-5085(00)70142-9 · DOI · Paper page
- Qiu, 2013, Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis, J. Crohn’s Colitis, 7, e558, 10.1016/j.crohns.2013.04.002 · DOI · Paper page
- Osterreicher, 2000, Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production, FASEB J., 14, 2380, 10.1096/fj.00-0359fje · DOI · Paper page
- Sokol, 2008, Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proc. Natl. Acad. Sci. USA, 105, 16731, 10.1073/pnas.0804812105 · DOI · Paper page
- Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J. Nutr., 139, 1619, 10.3945/jn.109.104638 · DOI · Paper page
- Clooney, 2018, Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis, J. Crohn’s Colitis, 12, 204, 10.1093/ecco-jcc/jjx137 · DOI · Paper page
- Song, 2022, Roseburia hominis Alleviates Neuroinflammation via Short-Chain Fatty Acids through Histone Deacetylase Inhibition, Mol. Nutr. Food Res., 66, e2200164, 10.1002/mnfr.202200164 · DOI · Paper page
- Singh, 2014, Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, 40, 128, 10.1016/j.immuni.2013.12.007 · DOI · Paper page
- Pan, 2024, Roseburia intestinalis: A possible target for vascular calcification, Heliyon, 10, e39865, 10.1016/j.heliyon.2024.e39865 · DOI
- Jiang, 2025, Roseburia intestinalis-derived butyrate alleviates neuropathic pain, Cell Host Microbe, 33, 104, 10.1016/j.chom.2024.11.013 · DOI
- Notting, 2023, The butyrate-producing and spore-forming bacterial genus Coprococcus as a potential biomarker for neurological disorders, Gut Microbiome, 4, e16, 10.1017/gmb.2023.14 · DOI
- Altemani, 2021, Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota, Pregnancy Hypertens., 23, 211, 10.1016/j.preghy.2021.01.002 · DOI
- Holdeman, 1974, New genus, Coprococcus, twelve new species, and emended descriptions of four previously described species of bacteria from human feces, Int. J. Syst. Evol. Microbiol., 24, 260
- Nogal, A., Louca, P., Zhang, X., Wells, P.M., Steves, C.J., Spector, T.D., Falchi, M., Valdes, A.M., and Menni, C. (2021). Circulating levels of the short-chain fatty acid acetate mediate the effect of the gut microbiome on visceral fat. Front. Microbiol., 12. · DOI · Paper page
- Falony, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat. Microbiol., 4, 623, 10.1038/s41564-018-0337-x · DOI · Paper page
- Xu, 2024, Coprococcus eutactus screened from healthy adolescent attenuates chronic restraint stress-induced depression-like changes in adolescent mice: Potential roles in the microbiome and neurotransmitter modulation, J. Affect. Disord., 356, 737, 10.1016/j.jad.2024.04.050 · DOI
- Wang, Z., Jiang, D., Zhang, M., Teng, Y., and Huang, Y. (2023). Causal association between gut microbiota and fibromyalgia: A Mendelian randomization study. Front. Microbiol., 14. · DOI
- Osawa, 2023, Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients, J. Clin. Biochem. Nutr., 73, 77, 10.3164/jcbn.22-86 · DOI
- Gronow, 2011, Complete genome sequence of Odoribacter splanchnicus type strain (1651/6), Stand. Genomic Sci., 4, 200, 10.4056/sigs.1714269 · DOI · Paper page
- Hajra, D., Mukherjee, D., Vij, R., Rajmani, R.S., Dadireddy, V., Das, D., Hussain, T., Ganji, M., Tatu, U., and Chakravortty, D. (2024). Odoribacter splanchnicus mitigates pathogen-induced gut inflammation and its associated pathogenesis via its secreted bacteriocin. bioRxiv. · DOI
- Si, 2025, Lactobacillus rhamnosus GG induces STING-dependent IL-10 in intestinal monocytes and alleviates inflammatory colitis in mice, J. Clin. Investig., 135, e174910, 10.1172/JCI174910 · DOI
- Khare, 2020, Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice, Sci. Rep., 10, 18597, 10.1038/s41598-020-75702-5 · DOI
- Klemenak, 2015, Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease, Dig. Dis. Sci., 60, 3386, 10.1007/s10620-015-3769-7 · DOI
- Cai, Y., Wen, S., Hu, J., Wang, Z., Huang, G., Zeng, Q., and Zou, J. (2024). Multiple reports on the causal relationship between various chronic pain and gut microbiota: A two-sample Mendelian randomization study. Front. Neurosci., 18. · DOI
- Bai, 2018, Fecal microbiota transplantation is effective in relieving visceral hypersensitivity in a postinfectious model, BioMed Res. Int., 2018, 3860743, 10.1155/2018/3860743 · DOI
- Shabani, 2023, Evaluating the Effects of Probiotic Supplementation on Neuropathic Pain and Oxidative Stress Factors in an Animal Model of Chronic Constriction Injury of the Sciatic Nerve, Basic. Clin. Neurosci., 14, 375, 10.32598/bcn.2022.3772.1 · DOI
- Wang, 2024, Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: A retrospective review, Eur. J. Med. Res., 29, 148, 10.1186/s40001-024-01747-1 · DOI
- Gardiner, 2015, Clinical and microbiological characteristics of Eggerthella lenta bacteremia, J. Clin. Microbiol., 53, 626, 10.1128/JCM.02926-14 · DOI · Paper page
- Alexander, 2022, Human gut bacterial metabolism drives Th17 activation and colitis, Cell Host Microbe, 30, 17, 10.1016/j.chom.2021.11.001 · DOI · Paper page
- Maeshima, N., and Fernandez, R.C. (2013). Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front. Cell. Infect. Microbiol., 3. · DOI · Paper page
- Pither, 2020, Pairing Bacteroides vulgatus LPS structure with its immunomodulatory effects on human cellular models, ACS Cent. Sci., 6, 1602, 10.1021/acscentsci.0c00791 · DOI · Paper page
- Uemura, Y., Hiroshima, Y., Tada, A., Murakami, K., Yoshida, K., Inagaki, Y., Kuwahara, T., Murakami, A., Fujii, H., and Yumoto, H. (2022). Porphyromonas gingivalis Outer Membrane Vesicles Stimulate Gingival Epithelial Cells to Induce Pro-Inflammatory Cytokines via the MAPK and STING Pathways. Biomedicines, 10. · DOI
- Ciaston, 2022, Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis, mBio, 13, e0378721, 10.1128/mbio.03787-21 · DOI
- Jenning, 2020, Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection—A missing link for ACPA production, Ann. Rheum. Dis., 79, 1194, 10.1136/annrheumdis-2019-216919 · DOI
- Yanagisawa, 2006, Proteinase activity of prevotella species associated with oral purulent infection, Curr. Microbiol., 52, 375, 10.1007/s00284-005-0261-1 · DOI
- Niu, 2023, Symbiotic relationship between Prevotella denticola and Streptococcus mutans enhances virulence of plaque biofilms, Arch. Oral Biol., 151, 105714, 10.1016/j.archoralbio.2023.105714 · DOI
- Yu, 2024, Solobacterium moorei promotes the progression of adenomatous polyps by causing inflammation and disrupting the intestinal barrier, J. Transl. Med., 22, 169, 10.1186/s12967-024-04977-3 · DOI
- Sugiyama, 2016, Activation of inflammasomes in dendritic cells and macrophages by Mycoplasma salivarium, Mol. Oral Microbiol., 31, 259, 10.1111/omi.12117 · DOI
200 of 235 shown
Cited by
Okui, N., Ichino, K., Ide, H., Matsushita, K., Ikehata, Y., Okui, M., & Horie, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-58586-9
Metadata
- Authors
- Ahmed, I., Nijs, J., Vanroose, M., Vandeputte, D., Kindt, S., Elma, Ö., Hendrix, J., Huysmans, E., & Lahousse, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2025-12-22
- Volume
- 27
- Issue
- 1
- Pages
- 114
- ISSN
- 1422-0067
- Cited by
- 13
- References
- 52
- Language
- en
- Funders
- Strategic Research Program SRP90
- Network for Social Impact of Science NSIS
- research council of the Vrije Universiteit Brussel, Brussels, Belgium
- cross-European Weave program 50
- Research Foundation Flanders (G0894322N)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.